Evidence map›Paper›PMID 32383132›Full record

ArticleInternational ophthalmology2020

Evaluation of the effect of smokeless tobacco (Maras powder) on choroidal and retinal blood flow: an optical coherence tomography angiography study.

Ayşegül Çömez, Yalçın Karaküçük, Abdullah Beyoğlu

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ayşegül ÇömezDepartment of Ophthalmology, Faculty of Medicine, Sutcu Imam University, Kahramanmaras, Turkey. draysegulcomez@gmail.com.ORCID http://orcid.org/0000-0002-2628-9426
Yalçın KaraküçükDepartment of Ophthalmology, Faculty of Medicine, Selcuk University, Konya, Turkey.
Abdullah BeyoğluDepartment of Ophthalmology, Faculty of Medicine, Sutcu Imam University, Kahramanmaras, Turkey.
Kahramanmaraş Sütçü İmam University · TRSelçuk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

absrtactPURPOSE: To investigate the acute and chronic effects of the use of smokeless tobacco (Maras powder) on macular and choroidal blood flow, via optical coherence tomography angiography (OCTA).

methodsThe study included 30 eyes of 30 patients using smokeless tobacco (ST) as the study group and 30 eyes of 30 healthy individuals as the control group. All subjects underwent a full ophthalmological examination, and baseline OCTA measurements were taken. Flow area in superficial capillary plexus (SCP), in deep capillary plexus (DCP), in choriocapillaris (mm

resultsThe SFCT measurements were determined to be significantly low in the study group (p < 0.001). In the comparison of the study group measurements at 5 m, 30 m and 1 h after using ST compared to the baseline measurements, SCP and DCP flow area, VD, CC flow area and SFCT were determined to have significantly decreased, statistically (p < 0.001).

conclusionOCTA could be important in showing that choroidal microvascular structures have been affected before occurence of the apparent clinical signs associated with acute and chronic ST use.

Indexed as

AdultChoroidCross-Sectional StudiesFemaleFluorescein AngiographyFollow-Up StudiesFundus OculiHumansMacula LuteaMaleProspective StudiesRegional Blood FlowRetinal VesselsTobacco, SmokelessTomography, Optical CoherenceFlow areaMaras powder (MP)Optical coherence tomography angiography (OCTA)Smokeless tobaccoSubfoveal choroidal thicknessVascular density

Identifiers

PMID32383132
OpenAlexW3022730221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.